These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 24796233)

  • 1. Color vision impairment in Parkinson's disease.
    Piro A; Tagarelli A; Nicoletti G; Fletcher R; Quattrone A
    J Parkinsons Dis; 2014; 4(3):317-9. PubMed ID: 24796233
    [No Abstract]   [Full Text] [Related]  

  • 2. [Disturbance of micturition in Parkinson's disease].
    Sakakibara R; Uchiyama T; Yoshiyama M; Hattori T
    No To Shinkei; 2001 Nov; 53(11):1009-14. PubMed ID: 11761908
    [No Abstract]   [Full Text] [Related]  

  • 3. Parkinson's disease.
    Clarke CE; Moore AP
    Am Fam Physician; 2007 Apr; 75(7):1045-8. PubMed ID: 17427619
    [No Abstract]   [Full Text] [Related]  

  • 4. Off and on state assessment of swallowing function in Parkinson's disease.
    Warnecke T; Hamacher C; Oelenberg S; Dziewas R
    Parkinsonism Relat Disord; 2014 Sep; 20(9):1033-4. PubMed ID: 24997546
    [No Abstract]   [Full Text] [Related]  

  • 5. The effects of levodopa on word intelligibility in Parkinson's disease.
    De Letter M; Santens P; Van Borsel J
    J Commun Disord; 2005; 38(3):187-96. PubMed ID: 15748723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperthyroidism "masked" the levodopa response in newly diagnosed Parkinson's disease patients.
    Prakash KM; Kek PC
    Parkinsonism Relat Disord; 2010 Dec; 16(10):691-2. PubMed ID: 20729126
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect of levodopa dose and body weight on dyskinesia in a prevalent population of people with Parkinson's disease.
    Walker RW; Howells AR; Gray WK
    Parkinsonism Relat Disord; 2011 Jan; 17(1):27-9. PubMed ID: 21051272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New treatment for Parkinson's disease.
    J R Soc Health; 1997 Jun; 117(3):179. PubMed ID: 9195833
    [No Abstract]   [Full Text] [Related]  

  • 9. Parkinson's disease and pain--nondopaminergic mechanisms are likely to be important too.
    Lim SY; Farrell MJ; Evans AH
    Mov Disord; 2011 Jun; 26(7):1353-4. PubMed ID: 21449013
    [No Abstract]   [Full Text] [Related]  

  • 10. Parkinson's disease: progression and mortality in the L-DOPA era.
    Di Rocco A; Molinari SP; Kollmeier B; Yahr MD
    Adv Neurol; 1996; 69():3-11. PubMed ID: 8615142
    [No Abstract]   [Full Text] [Related]  

  • 11. Unexpected improvement in levodopa-induced dyskinesia and on-off phenomena after introduction of memantine for treatment of Parkinson's disease dementia.
    Vidal EI; Fukushima FB; Valle AP; Villas Boas PJ
    J Am Geriatr Soc; 2013 Jan; 61(1):170-2. PubMed ID: 23311565
    [No Abstract]   [Full Text] [Related]  

  • 12. Prosody and levodopa in Parkinson's disease.
    Azevedo LL; Reis CA; Souza IS; Cardoso FE
    Arq Neuropsiquiatr; 2013 Nov; 71(11):835-40. PubMed ID: 24394867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levodopa and the progression of Parkinson's disease.
    Walton-Hadlock JL
    N Engl J Med; 2005 Mar; 352(13):1386; author reply 1386. PubMed ID: 15800240
    [No Abstract]   [Full Text] [Related]  

  • 14. Bruxism as presenting feature of Parkinson's disease.
    Srivastava T; Ahuja M; Srivastava M; Trivedi A
    J Assoc Physicians India; 2002 Mar; 50():457. PubMed ID: 11922248
    [No Abstract]   [Full Text] [Related]  

  • 15. Parkinson's disease.
    Barboi AC; Goetz CG
    Clin Neuropharmacol; 1999; 22(4):184-91. PubMed ID: 10442246
    [No Abstract]   [Full Text] [Related]  

  • 16. Prevalence of non-motor dysfunction among Parkinson's disease patients from a tertiary referral center in Mexico City.
    Rodríguez-Violante M; Cervantes-Arriaga A; Villar-Velarde A; Corona T
    Clin Neurol Neurosurg; 2010 Dec; 112(10):883-5. PubMed ID: 20800345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Swallowing improvement after levodopa treatment in idiopathic Parkinson's disease: lack of evidence.
    Melo A; Monteiro L
    Parkinsonism Relat Disord; 2013 Mar; 19(3):279-81. PubMed ID: 23231973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Parkinson's disease following hypothyroidism: clinical and therapeutic implications].
    Kacem I; Gargouri A; Ben Djebara M; Khamassi N; Cherif W; Gouider R
    Tunis Med; 2013 Feb; 91(2):168-70. PubMed ID: 23526270
    [No Abstract]   [Full Text] [Related]  

  • 19. Pattern of subclinical pulmonary dysfunctions in Parkinson's disease and the effect of levodopa.
    Pal PK; Sathyaprabha TN; Tuhina P; Thennarasu K
    Mov Disord; 2007 Feb; 22(3):420-4. PubMed ID: 17230476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Levodopa therapeutics for Parkinson's disease: new developments.
    LeWitt PA
    Parkinsonism Relat Disord; 2009 Jan; 15 Suppl 1():S31-4. PubMed ID: 19131040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.